Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Catalyst Pharmaceuticals Inc    CPRX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/27/2015 07/28/2015 07/29/2015 07/30/2015 07/31/2015 Date
5.22(c) 5.23(c) 4.92(c) 4.89(c) 4.94(c) Last
660 848 612 770 664 740 587 869 502 219 Volume
-1.51% +0.19% -5.93% -0.61% +1.02% Change
More quotes
Financials ($)
Sales 2015 -
EBIT 2015 -27,6 M
Net income 2015 -28,2 M
Debt 2015 -
Yield 2015 -
Sales 2016 16,7 M
EBIT 2016 -22,9 M
Net income 2016 -21,2 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 0
Capi. / Sales 2016 24,3x
Capitalization 405 M
More Financials
Company
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.The company has three drug candidates in development: Firdapse, CPP-115 and CPP-109.The company was founded by McEnany J. Patrick... 
More about the company
Surperformance© ratings of Catalyst Pharmaceuticals I
Trading Rating : Investor Rating : -
More Ratings
Latest news on CATALYST PHARMACEUTICALS I
07/23 CATALYST PHARMACEUTICALS : Initiates Rolling NDA Submission for Firdapse for the..
07/22 Catalyst Pharmaceuticals Initiates Rolling NDA Submission for Firdapse for th..
06/30 CATALYST PHARMACEUTICALS : Joins Russell 2000, 3000 and Global Indexes
06/30 Catalyst Pharmaceuticals Appoints Dr. Gary Ingenito as Chief Medical Officer
06/29 Catalyst Pharmaceuticals Joins Russell 2000, 3000 and Global Indexes
06/26 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Announces Encouraging Top-Lin..
06/24 Catalyst Pharmaceuticals Announces Encouraging Top-Line Results in Proof-of-C..
05/28 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Names Richard J. Daly Interim..
More news
Sector news : Bio Therapeutic Drugs
07/31 QUINTILES TRANSNATIONAL : Announces Pricing of Secondary Public Offering
07/30 SEATTLE GENETICS : reports 2Q loss
07/30 QUINTILES TRANSNATIONAL : Announces Launch of Secondary Public Offering of Commo..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
07/22 Catalyst Pharma starts rolling NDA submission for Firdapse in LEMS
06/24 Catalyst Pharma's CPP-109 shows promising results in Tourette's Disorder; sha..
06/24 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
05/19 Midday Gainers / Losers
05/11 Catalyst Pharmaceutical beats by $0.02


Comments 
Advertisement
Chart CATALYST PHARMACEUTICALS I
Duration : Period :
Catalyst Pharmaceuticals I Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Technical analysis trends CATALYST PHARMACE...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions